This site is intended for healthcare professionals only
LoginRegister
Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indicationBayer Takes Roundup Cancer Case Back to Supreme Court
Centre Issues Medical Devices Amendment Rules 2026CDSCO issues revised Risk Based Classification of Cardiovascular and neurological medical devices;...
COVID Vaccine Trial Setback: Pfizer, BioNTech Halt Study Over Low EnrollmentPfizer Gets CDSCO Panel Nod To study Marstacimab
Accused ArrestedFake pharmacy registration racket busted, Delhi Pharmacy Council former employee, 46 others arrested
Alembic buys UTI-focused Utility Therapeutics in USD 12 million dealEmcure Pharma European arm Tillomed buys strategic pharma portfolio from Manx for 19.7 million...
AstraZeneca to Invest USD 15 Billion in China by 2030AstraZeneca Imfinzi-based perioperative regimen approved in EU for resectable non-small cell lung...
USFDA Raises Safety Alert on Amgens Tavneos After Liver Injury, Death Cases SurfaceUSFDA grants nod for Amgen Uplizna as first treatment for rare immune disorder
Natco PharmaNatco Pharma Executive VP - Technology Transfer, Intellectual Property Rights & Regulatory Affairs...
Shilpa Medicare bags initial authorization for Rotigotine Transdermal Patch from EuropeShilpa Medicare marketing partner Amneal Pharma unveils multiple myeloma treatment Boruzu
Novo Nordisk reshapes Executive management teamNovo Nordisk reshapes Executive management team
Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indicationBayer AG arm Vividion Therapeutics doses first patient in Phase I study of Inhibitor for advanced...
Zydus Wellness Arm Faces Rs 6.3 Million GST Penalty Over ITC IrregularitiesZydus Lifesciences gets CDSCO panel nod to conduct bioequivalence study of Eltrombopag for oral...
X